Polaryx Therapeutics

PLYXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$112.652 M

$2.26 +1.80%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$8.98M

Loss-making

Shares outstanding

47,343,297

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#302Cue BiopharmaCUE$113.9M
#303Coya TherapeuticsCOYA$112.8M
#304Polaryx TherapeuticsPLYX$112.7M
#305RafaelRFL$106.6M
#306Rani TherapeuticsRANI$98.1M

Where these numbers come from

Share counts and financials for Polaryx Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.